Synairgen (SNG)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

163.50p
   
  • Change Today:
    -1.90p
  • 52 Week High: 224.66
  • 52 Week Low: 77.00
  • Currency: UK Pounds
  • Shares Issued: 201.34m
  • Volume: 1,126,401
  • Market Cap: 329.19m
  • RiskGrade: 510
Select chart: 1 week | 1 month | 3 month | 6 month
 

Current

1 week

Forecasts

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-21 293.00 233.00 99.90p 1.6 n/a n/a 4.00p 2.3%
31-Dec-22 582.50 512.50 220.00p 0.7 0.0 +120% 5.00p 2.9%

Copyright © 2021 FactSet Research Systems Inc. All rights reserved.

Trends & Recommendations

  Current 1 week ago 1 month ago 3 months ago 6 months ago 1 year ago
Revenue (m)
31-Dec-2021 293 293 293 293 293 n/a
31-Dec-2022 582 582 0 0 0 n/a
 
Earnings
31-Dec-2021 99.90p 99.90p 32.50p 32.50p 48.15p n/a
31-Dec-2022 220.00p 220.00p n/a n/a n/a n/a
 
Dividend
31-Dec-2021 4.00p 4.00p 2.00p 2.00p 2.00p n/a
31-Dec-2022 5.00p 5.00p n/a n/a n/a n/a
 
Recommendations
Strong Buy 1 1 1 1 1 0
Buy 0 0 0 0 0 0
Neutral 0 0 0 0 0 0
Sell 0 0 0 0 0 0
Strong Sell 0 0 0 0 0 0
No. of Brokers 1 1 1 1 1 0
 
Average Rec 10.00 10.00 10.00 10.00 10.00 n/a

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Broker estimates sourced from FactSet Estimates +44 (0) 20 3009 7000. FactSet Estimates calculate consensus using only those estimates changed or actively validated within the last 75 days.

Note 4: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 5: Forecast figures based on normalised accounts.

 

IFRS Changes - Find Out More

Find out about IFRS and how this affects the financial infomation for all UK companies.

Synairgen Market Data

Currency UK Pounds
Share Price 163.50p
Change Today -1.90p
% Change -1.15 %
52 Week High 224.66
52 Week Low 77.00
Volume 1,126,401
Shares Issued 201.34m
Market Cap 329.19m
RiskGrade 510

Synairgen Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
46.56% above the market average46.56% above the market average46.56% above the market average46.56% above the market average46.56% above the market average
92.00% above the sector average92.00% above the sector average92.00% above the sector average92.00% above the sector average92.00% above the sector average
Price Trend
2.05% below the market average2.05% below the market average2.05% below the market average2.05% below the market average2.05% below the market average
16.13% above the sector average16.13% above the sector average16.13% above the sector average16.13% above the sector average16.13% above the sector average
Income
5.09% above the market average5.09% above the market average5.09% above the market average5.09% above the market average5.09% above the market average
63.64% above the sector average63.64% above the sector average63.64% above the sector average63.64% above the sector average63.64% above the sector average
Growth Not Available

What The Brokers Say

Strong Buy 1
Buy 0
Neutral 0
Sell 0
Strong Sell 0
Total 1
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Synairgen Dividends

No dividends found

Trades for 21-Sep-2021

Time Volume / Share Price
16:35 8,082 @ 163.50p
16:29 14 @ 161.50p
16:29 27 @ 161.50p
16:29 11 @ 161.50p
16:29 531 @ 161.60p

Synairgen Key Personnel

CEO Richard J Marsden
Finance Director John C Ward

Top of Page